Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias.

Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias. Expert Opin Investig Drugs. 2001 Aug; 10(8):1521-30.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.